| Weight | 1 lbs |
|---|---|
| Dimensions | 9 × 5 × 2 in |
| target | Herpes Simplex Virus 1+2 reactive IgG |
| species reactivity | Herpes Simplex Virus |
| applications | ELISA |
| assay type | Indirect & quantitative |
| available size | 3 mL |
Herpes Simplex Virus 1+2 IgG Control Serum BC105G
$94.00
Summary
- Virion/Serion Diagnostic Kit Control for research use (RUO)
- Herpes Simplex Virus (HSV) 1+2 IgG Control Serum
- Applications: ELISA
- IgG control serum
- Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
- 3 mL
Herpes Simplex Virus 1+2 IgG Control Serum BC105G
| target relevance |
|---|
| Organism Herpes Simplex Virus 1/2 |
| Protein names Herpes Simplex Virus (HSV) |
| Structure and strains Herpes simplex virus 1 and 2 (HSV-1 and HSV-2), also known by their taxonomic names Human alphaherpesvirus 1 and Human alphaherpesvirus 2, are two members of the human Herpesviridae family, a set of viruses that produce viral infections in the majority of humans. Both HSV-1 and HSV-2 are very common and contagious. They can be spread when an infected person begins shedding the virus. As of 2016, about 67% of the world population under the age of 50 had HSV-1. In the United States, about 47.8% and 11.9% are estimated to have HSV-1 and HSV-2, respectively, though actual prevalence may be much higher. Because it can be transmitted through any intimate contact, it is one of the most common sexually transmitted infections. |
| Detection and diagnosis An important field of application for HSV serology - also during latency - is the detection of serotype-specific HSV IgG antibodies in order to identify potential HSV carriers who could infect susceptible individuals. In particular, the identification of HSV 2 serotype-specific antibodies in pregnant women, who present a high risk of transferring the virus to a newborn child, is recommended. The serological typing of an HSV infection is usually performed by identifying IgG antibodies directed against the viral surface glycoproteins G (gG) of HSV 1 (gG1) and HSV 2 (gG2). Due to the fact that these antibodies are only produced some weeks after a primary infection, the determination of serotype-specific antibodies can also assist in the differentiation between primary infection and reactivation |
Data
FAQ & Publications
Frequently Asked Questions
What is the intended application for the Herpes Simplex Virus 1+2 IgG Control Serum BC105G?
This control serum is designed for use in ELISA applications, specifically for indirect and quantitative assays targeting Herpes Simplex Virus 1 and 2 IgG antibodies.
How should the Herpes Simplex Virus 1+2 IgG Control Serum BC105G be stored to maintain stability?
The serum should be stored refrigerated at 2-8°C to ensure proper preservation and stability.
Is the Herpes Simplex Virus 1+2 IgG Control Serum BC105G ready to use directly in SERION ELISA assays?
Yes, this control serum is supplied ready-to-use and pre-diluted for compatibility with SERION ELISA classic and SERION ELISA antigen assays.
What specific target does the Herpes Simplex Virus 1+2 IgG Control Serum BC105G detect?
It detects IgG antibodies reactive to Herpes Simplex Virus types 1 and 2, enabling serotype-specific identification of HSV infections.
Can this control serum be used as a reference in research related to infectious diseases involving HSV?
Yes, it is intended for research use only and is suitable as a kit control serum in studies of infectious diseases, particularly those involving Herpes Simplex Virus 1 and 2.
Publications
| pmid | title | authors | citation |
|---|---|---|---|
| We haven't added any publications to our database yet. | |||
Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.
Protocols
| relevant to this product |
|---|
| BC105G protocol |
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.